tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

SWTX Stock Latest News

SpringWorks should be bought on weakness, says JPMorgan
The FlySpringWorks should be bought on weakness, says JPMorgan
9d ago
SWTX
TD sees ‘some disappointment’ with lack of SpringWorks Therapeutics M&A news
PremiumThe Fly
TD sees ‘some disappointment’ with lack of SpringWorks Therapeutics M&A news
9d ago
SWTX
SpringWorks Therapeutics Reports Strong 2024 Financial Results
PremiumCompany Announcements
SpringWorks Therapeutics Reports Strong 2024 Financial Results
10d ago
8K
SWTX
SpringWorks Therapeutics sees Q4 U.S. OGSIVEO net revenue $61.5M
PremiumThe Fly
SpringWorks Therapeutics sees Q4 U.S. OGSIVEO net revenue $61.5M
10d ago
SWTX
SpringWorks Therapeutics rumor highlighted in Betaville alert
PremiumThe Fly
SpringWorks Therapeutics rumor highlighted in Betaville alert
12d ago
SWTX
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
12d ago
VIR
CRMD
SpringWorks Therapeutics price target lowered to $78 from $80 at Guggenheim
Premium
The Fly
SpringWorks Therapeutics price target lowered to $78 from $80 at Guggenheim
15d ago
SWTX
SpringWorks Therapeutics price target lowered to $55 from $58 at BofA
Premium
The Fly
SpringWorks Therapeutics price target lowered to $55 from $58 at BofA
16d ago
SWTX
SpringWorks Therapeutics initiated with an Outperform at Evercore ISI
PremiumThe Fly
SpringWorks Therapeutics initiated with an Outperform at Evercore ISI
2M ago
SWTX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
RNA
AGEN
Immunome price target lowered to $21 from $23 at Piper Sandler
PremiumThe Fly
Immunome price target lowered to $21 from $23 at Piper Sandler
2M ago
IMNM
SWTX
SpringWorks Therapeutics Q3 2024 Results Overview
PremiumCompany Announcements
SpringWorks Therapeutics Q3 2024 Results Overview
2M ago
SWTX
SpringWorks price target lowered to $74 from $76 at H.C. Wainwright
PremiumThe FlySpringWorks price target lowered to $74 from $76 at H.C. Wainwright
2M ago
SWTX
SpringWorks Therapeutics reports Q3 EPS (72c), consensus (75c)
Premium
The Fly
SpringWorks Therapeutics reports Q3 EPS (72c), consensus (75c)
2M ago
SWTX
SpringWorks Therapeutics announces data on mirdametinib
Premium
The Fly
SpringWorks Therapeutics announces data on mirdametinib
2M ago
SWTX
SpringWorks Therapeutics’ mirdametinib shows efficacy in neurofibromatosis study
PremiumThe Fly
SpringWorks Therapeutics’ mirdametinib shows efficacy in neurofibromatosis study
2M ago
SWTX
SWTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
SWTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
SWTX
SpringWorks Therapeutics’ ogsiveo shows long-term efficacy in Phase 3 trial
PremiumThe Fly
SpringWorks Therapeutics’ ogsiveo shows long-term efficacy in Phase 3 trial
3M ago
SWTX
SpringWorks Therapeutics price target raised to $68 from $64 at JPMorgan
PremiumThe Fly
SpringWorks Therapeutics price target raised to $68 from $64 at JPMorgan
5M ago
SWTX
SpringWorks Therapeutics: FDA grants priority review to NDA for mirdametinib
PremiumThe FlySpringWorks Therapeutics: FDA grants priority review to NDA for mirdametinib
5M ago
SWTX
SpringWorks Therapeutics price target raised to $76 from $74 at H.C. Wainwright
Premium
The Fly
SpringWorks Therapeutics price target raised to $76 from $74 at H.C. Wainwright
6M ago
SWTX
SpringWorks Therapeutics reports Q2 EPS (54c), consensus ($1.11)
Premium
The Fly
SpringWorks Therapeutics reports Q2 EPS (54c), consensus ($1.11)
6M ago
SWTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >